Cancer

New diagnoses and a history of non-melanoma skin cancer have become increasingly common, and the disease affects more individuals than all other cancers combined, according to new US reports.

Patients with gastric ulcers are at increased risk of pancreatic cancer, but the association is not the same for duodenal ulcers, a large prospective study finds.

Women with breast cancer who take the antidepressant paroxetine at the same time as tamoxifen are at an increased risk of death, a new Canadian study has found.

The longer women wait for radiotherapy after breast cancer surgery, the more chance there is of local recurrence, concludes a study published in the British Medical Journal.

Prof John Reynolds, of St James’s Hospital, Dublin and TCD, examines the causes of oesophageal cancer and the enormous advances which have taken place in the management of the disease in recent years {openx:269} Lollipop Day at this time of year (February 26 and 27) raises awareness of cancer of the oesophagus.

A new software package aims to provide medical professionals and patients with information on breakthrough cancer pain and how to treat it {openx:269} An innovative e-learning tool is being launched in Ireland to provide medical professionals and patients with a comprehensive insight into breakthrough cancer pain and its treatment.

Classifying lyphoma types is only the first difficulty for physicians working in the area.

Rory Hafford talks to Dr John McCaffrey about improvements in the management of RCC, the rise in presenting cases and his long-lost fondness for jogging {openx:269} There is a reassuring calmness about Dr John McCaffrey; you can hear it in his tone, see it in his manner.

Dr Jennifer Gilmore and Dr Ian Fraser look at the issue of using radiotherapy in patients with breast cancer and examine ways to make optimum use of the treatment {openx:269} Which patients will receive radiotherapy? The majority of women who have surgery for breast cancer will receive adjuvant radiotherapy.

A comparison of outcomes of different eras of conservative treatment for localised prostate cancer indicates that overall and prostate cancer-specific survival rates are higher for men diagnosed from 1992 through 2002, when compared to men diagnosed in the 1970s and 1980s, according to a new study.